Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017

被引:4
|
作者
Hagiya, Hideharu [1 ]
Koyama, Toshihiro [6 ]
Deguchi, Matsuo
Minato, Yusuke [5 ]
Miura, Satomi [6 ]
Funahashi, Tomoko
Teratani, Yusuke
Zamami, Yoshito
Shinomiya, Kazuaki [7 ]
Kitamura, Yoshihisa [3 ]
Sendo, Toshiaki [4 ]
Hinotsu, Shiro [8 ]
Kano, Mitsunobu [2 ]
机构
[1] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Pharmaceut Biomed,Grad Sch Med Dent & Pharmaceut, Okayama, Japan
[2] Okayama Univ, Pharmaceut Biomed, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Okayama, Japan
[3] Shujitsu Univ, Sch Pharm, Dept Pharmacotherapy, Okayama, Japan
[4] Okayama Univ Hosp, Dept Pharm, Okayama, Japan
[5] Fujita Hlth Univ, Dept Microbiol, Sch Med, Toyoake, Aichi, Japan
[6] Tokushima Univ, Inst Biomed Sci, Dept Clin Pharmacol & Therapeut, Grad Sch, Tokushima, Japan
[7] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Clin Pharm, Tokushima, Japan
[8] Sapporo Med Univ, Dept Biostat & Data Management, Sapporo, Hokkaido, Japan
基金
日本学术振兴会;
关键词
death certificate; hepatitis C; mortality; vital statistics; VIRAL-HEPATITIS; NATIONAL-SURVEY; UNITED-STATES; B-VIRUS; COMBINATION; THERAPY; BURDEN; PEGINTERFERON; INFORMATION; SIMEPREVIR;
D O I
10.1111/jgh.15517
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim The current prevalence of hepatitis C virus infection and hepatitis C virus-associated mortality in Japan falls short of the World Health Organization goal of viral hepatitis elimination by 2030. We aimed to evaluate the trends in hepatitis C virus-associated mortality in Japan. Methods This nationwide observational study used the Japanese Vital Statistics from 1998 to 2017 and included all Japanese hepatitis C virus-associated deaths (84 936) of adults aged >= 40 years. We calculated the crude and age-standardized mortality rates per 100 000 persons by age and sex. Joinpoint regression analysis was used to identify significant changing points in trends and to estimate the annual percentage changes and the average annual percentage changes for the entire study period. Results The crude mortality rate per 100 000 persons (annual death number) increased from 5.5 (3548) in 1998 to 7.0 (4843) in 2005 and decreased to 4.0 (3095) in 2017. By 2017, the crude mortality rates per 100 000 persons among men and women had dropped to 3.6 and 4.3, respectively. The age-standardized mortality rate was higher in women than in men. The average annual percentage change was -3.8% (95% confidence interval: -5.0 to -2.5). The declining trend was more rapid in men (-4.5%, 95% confidence interval: -5.3 to -3.6) than in women (-2.7%, 95% confidence interval: -3.8 to -1.6). Conclusions Trends in hepatitis C virus-associated mortality rates have declined in an accelerating manner in Japan, especially among men.
引用
收藏
页码:2486 / 2492
页数:7
相关论文
共 50 条
  • [41] Hepatitis C mortality trends in Mexico from 2001 to 2017
    Martinez-Bohorquez, Maria Carolina
    Carnalla, Martha
    Chavez-Tapia, Norberto
    Barrientos-Gutierrez, Tonatiuh
    ANNALS OF HEPATOLOGY, 2023, 28 (03)
  • [42] Hepatitis C virus-associated indolent B-therapy
    Mazzaro, Cesare
    Dal Maso, Luigino
    Visentini, Marcella
    Ermacora, Anna
    Andreone, Pietro
    Gattei, Valter
    Pozzato, Gabriele
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (04) : 439 - 447
  • [43] Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017
    Park, Seung Ha
    Plank, Lindsay D.
    Suk, Ki Tae
    Park, Yong Eun
    Lee, Jin
    Choi, Joon Hyuk
    Heo, Nae Yun
    Park, Jongha
    Kim, Tae Oh
    Moon, Young Soo
    Kim, Hyun Kuk
    Jang, Hang Jea
    Park, Ha Young
    Kim, Dong Joon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (02) : 209 - 215
  • [44] Therapy of hepatitis C virus-associated glomerulonephritis: current approaches
    Fabrizi, Fabrizio
    Lunghi, Giovanna
    Messa, Piergiorgio
    Martin, Paul
    JOURNAL OF NEPHROLOGY, 2008, 21 (06) : 813 - 825
  • [45] Hepatitis C virus-associated rapidly progressive glomerulonephritis.
    Kissinger, G
    Pollok, M
    Baldamus, CA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2647 - A2647
  • [46] Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
    Youssef Alhmada
    Denis Selimovic
    Fadi Murad
    Sarah-Lilly Hassan
    Youssef Haikel
    Mossaad Megahed
    Matthias Hannig
    Mohamed Hassan
    World Journal of Gastroenterology, 2017, 23 (05) : 743 - 750
  • [47] Hepatitis C Virus-Associated Acalculous Cholecystitis and Review of the Literature
    Wright, William F.
    Palisoc, Kathryn
    Pinto, Casey N.
    Lease, James A.
    Baghli, Salim
    CLINICAL MEDICINE & RESEARCH, 2020, 18 (01) : 33 - 36
  • [48] Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
    Alhmada, Youssef
    Selimovic, Denis
    Murad, Fadi
    Hassan, Sarah-Lilly
    Haikel, Youssef
    Megahed, Mossaad
    Hannig, Matthias
    Hassan, Mohamed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (05) : 743 - 750
  • [49] Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts
    Cruzado, JM
    GilVernet, S
    Ercilla, G
    Seron, D
    Carrera, M
    Bas, J
    Torras, J
    Alsina, J
    Grinyo, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (11): : 2469 - 2475
  • [50] Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy
    Komatsuda, A
    Imai, H
    Wakui, H
    Hamai, K
    Ohtani, H
    Kodama, T
    Oyama, Y
    Miura, AB
    Nakamoto, Y
    INTERNAL MEDICINE, 1996, 35 (07) : 529 - 533